Huberman Lab avatar

Dexa/Huberman Lab

Supported byHuberman Lab
Learn more

Neuroplasticity and Ketamine

NMDA receptors play a pivotal role in neuroplasticity, detecting unusual brain activity and facilitating cellular changes. Ketamine, as an NMDA receptor antagonist, intriguingly promotes neuroplasticity, aiding in the transition from depression. The balance between excitatory and inhibitory neurotransmission is crucial, with disruptions potentially leading to conditions like epilepsy, characterized by excessive brain excitation.
  • In this clip

  • From this podcast

    Huberman Lab avatar

    Huberman Lab

    Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity | Huberman Lab Podcast

  • Related Questions

    • How does the NMDA receptor work in the context of ketamine's effects on depression, PTSD, and neuroplasticity as discussed in the episode Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity | Huberman Lab Podcast and the clip Neuroplasticity and Ketamine?

    • How does the NMDA receptor work in the context of ketamine's effects on depression, PTSD, and neuroplasticity as discussed in the episode "Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity | Huberman Lab Podcast" and the clip "Neural Circuits of Depression"?

    • How does the NMDA receptor work in the context of ketamine's effects on depression, PTSD, and neuroplasticity as discussed in the episode Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity | Huberman Lab Podcast and the clip Neuroplasticity and Ketamine?

Built by
Charlie AI
© 2024 Huberman LabTermsPrivacyDisclaimerSupport